The Newsroom    Published Friday, Nov. 6, 2009, 10:00 AM
Print   |   
« Back   |   

New insulin study may open doors for better treatment of sarcopenia

Scienceline, November 5, 2009

Scienceline, Nov. 5, 2009

A study in the journal Diabetologia by UTMB researchers found that insulin might play an important role in sarcopenia, age-related muscled loss. Sarcopenia occurs in part because muscle tissue doesn’t respond properly to insulin. Although researchers found that increased dosage of insulin restored muscle-building processes, it cannot be used in treatment because of its toxicity in high concentrations. “The new finding serves as a proof of concept,” said UTMB Dr. Elena Volpi. “It confirms our belief that the age-related decline in muscle growth is a true case of insulin resistance, which is an important piece to the larger puzzle of treating sarcopenia.”




Follow Us:
The Newsroom is a service provided by the Office of Public Affairs  •  Questions or Comments?